Skip to main content
Clinical Trials/NCT02942862
NCT02942862CompletedNot Applicable

Evaluation of New Histoprognostic Criteria in a Retrospective Study of Colon Cancers Operated at Amiens University Hospital

Centre Hospitalier Universitaire, Amiens1 site in 1 country231 target enrollmentStarted: February 2015Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
231
Locations
1
Primary Endpoint
survival

Study Overview

Brief Summary

Colon cancer is a very common cancer. Prognosis and adjuvant treatment depend on the pathological results. Histoprognostic new factors have recently been published by several authors, but their validity is still debated.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients operated on for colon adenocarcinoma between 2004 and 2009 at the University Hospital of Amiens

Exclusion Criteria

  • Non-operated patients
  • Patients operated on before 2004 or after 2009
  • Patients operated in another center
  • The other histological types
  • Vicinity of tumors invading the colon by contiguity
  • Colic metastasis
  • Patients whose blocks or blades were not found in the archives.

Outcomes

Primary Outcomes

survival

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials